Arkolith/Insider Trading/ALLO/Form 4

Douglas Earl Martin

SVP, General CounselAllogene Therapeutics, Inc. (ALLO) · full profile →Form 4 · filed Aug 23, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 21, 2024Tax withholding(F)28K$2.79$79K449K

Transaction Codes

F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001593968-24-001096) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML